Palisade Bio
Pharmaceuticals, 7750 El Camino Real Ste 5200, Carlsbad, California, 92009, United States, 11-50 Employees
Phone Number: 85********
Who is PALISADE BIO
Palisade Bio is a biopharmaceutical company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. The Company believes that addressing t...
Read More
-
Headquarters: 7750 El Camino Real Ste 5200, Carlsbad, California, 92009, United States
-
Date Founded: 2005
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 523910 |
Show More
Does something look wrong? Fix it. | View contact records from PALISADE BIO
Palisade Bio Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Palisade Bio
Answer: Palisade Bio's headquarters are located at 7750 El Camino Real Ste 5200, Carlsbad, California, 92009, United States
Answer: Palisade Bio's phone number is 85********
Answer: Palisade Bio's official website is https://palisadebio.com
Answer: Palisade Bio's revenue is $1 Million to $5 Million
Answer: Palisade Bio's SIC: 2834
Answer: Palisade Bio's NAICS: 523910
Answer: Palisade Bio has 11-50 employees
Answer: Palisade Bio is in Pharmaceuticals
Answer: Palisade Bio contact info: Phone number: 85******** Website: https://palisadebio.com
Answer: Palisade Bio is a biopharmaceutical company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. The Company believes that addressing the disruption of the intestinal barrier can fundamentally change the way diseases are treated and establish new standards of patient care. Palisade Bios lead program, PALI-2108 is a microbiota-activated PDE4 inhibitor prodrug being developed for the treatment of moderate-to-severe ulcerative colitis and is advancing toward the completion of IND-enabling studies and an IND filing. The Companys second lead program, PALI-1908, is being evaluated in preclinical development for the treatment of fibrostenotic Crohns Disease.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month